New blood tests for Alzheimer's are emerging but lack FDA approval and insurance coverage, making it challenging for doctors to decide which tests to trust.
Some tests are highly accurate, while others are no better than chance, highlighting the need for more data to guide diagnostics and treatment decisions.
Collection
[
|
...
]